Syncona Limited NPV (SYNC)

Sector:

Investment Firms

Index:

FTSE 250

99.70p
   
  • Change Today:
      0.20p
  • 52 Week High: 130.60p
  • 52 Week Low: 99.50p
  • Currency: UK Pounds
  • Shares Issued: 631.82m
  • Volume: 482,080
  • Market Cap: £629.92m
  • RiskGrade: 291
  • Beta: 0.62

Syncona reports slight dip in net assets

By Josh White

Date: Thursday 10 Aug 2023

LONDON (ShareCast) - (Sharecast News) - Healthcare investor Syncona reported a slight dip in net assets in its quarterly update on Thursday, to £1.24bn, down from £1.26bn at the end of March.
The company said that change also affected the per-share value, with a decrease from 186.5p to 184.6p, resulting in a net asset value (NAV) return of -1% for the quarter.

It said the primary factor behind the performance was the negative foreign exchange movements, notably sterling appreciation on the dollar.

That, Syncona said, had led to a net decline of £14.8m.

However, there was some positive news in the life science portfolio, which saw its value increase from £604.6m to £628.7m.

That increment, mainly due to a surge in the share price of Autolus Therapeutics, somewhat offset the impact of foreign exchange.

During the period, Syncona also deployed £24.4m, with a remaining capital pool of £613.1m as at 30 June, down from £650.1m in March.

"We are pleased by progress throughout the portfolio during the period, as our companies work towards their next operational, clinical and commercial milestones," said Chris Hollowood at Syncona Investment Management.

"The expected late-stage data from our newest company Beacon, and Autolus' upcoming BLA filing, represent significant near-term milestones as our later-stage companies move closer towards bringing products to patients.

"Whilst the financing environment for biotech companies continues to be challenging, our capital pool of £613.1m allows us to support our portfolio companies as they navigate these market conditions and we have also been delighted to see continued strong pharma interest in our portfolio."

Syncona said it had seven clinical-stage companies across its "increasingly diversified" portfolio, adding that it was confident in their ability to execute on their key milestones.

"We believe the portfolio offers a significant opportunity to realise our ambition to bring transformational treatments to patients and deliver strong risk-adjusted returns to shareholders."

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

SYNC Market Data

Currency UK Pounds
Share Price 99.70p
Change Today 0.20p
% Change 0.20 %
52 Week High 130.60p
52 Week Low 99.50p
Volume 482,080
Shares Issued 631.82m
Market Cap £629.92m
Beta 0.62
RiskGrade 291

SYNC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
35.74% above the sector average35.74% above the sector average35.74% above the sector average35.74% above the sector average35.74% above the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
85.53% below the sector average85.53% below the sector average85.53% below the sector average85.53% below the sector average85.53% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
82.27% above the sector average82.27% above the sector average82.27% above the sector average82.27% above the sector average82.27% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SYNC Dividends

  Latest Previous
  Final Final
Ex-Div 21-Jun-18 20-Jul-17
Paid 30-Jul-18 23-Aug-17
Amount 2.30p 2.30p

Trades for 21-Nov-2024

Time Volume / Share Price
16:59 18,248 @ 99.50p
16:22 206 @ 99.60p
16:21 2,171 @ 99.80p
16:15 358 @ 99.80p
16:09 200 @ 99.70p

SYNC Key Personnel

Chair Melanie Gee

Top of Page